Netherlands· NL-c4f088d1e6fb
Byteqi 0,5 mg + 1 mg filmomhulde tabletten
A varenicline product containing vareniclinecitraat + vareniclinecitraat, registered in Netherlands by neuraxpharm Arzneimittel GmbH. The same ATC class is registered in 16 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Varenicline is registered in 16 of 19 countries.
Countries holding a registration under ATC N07BA03 (varenicline), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 9 of them publish a price we can compare per daily dose
Varenicline · ATC N07BA03
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of varenicline costs, country by country.
Normalised to the WHO defined daily dose (2 mg), the median price runs from $0.94 in United States to $22.43 in Italy — a ×24 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Varenicline · price per daily dose (2 mg)
USD · FX 28 Sept 2026
- IT Italy$22.43
- US United States$0.94 (acquisition cost)
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- VARENICLINECITRAAT + VARENICLINECITRAAT
- Manufacturer
- neuraxpharm Arzneimittel GmbH
- Country
- Netherlands (NL)
- ATC code
- N07BA03
- ATC class
- Varenicline
- Defined daily dose
- 2 mg, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id132198
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
143 interactions on record for varenicline.
Graded by severity as the source publishes them — 6 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Varenicline · interactions on record
143 records
- 6 moderate
- 1 minor
- 136 info
Most severe, free to view
- EthanolB05XX04moderate
- VandetanibL01EX04moderate
- VandetanibL01XE12moderate
- EthanolV03AB16moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Varenicline in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesCHANTIXPfizer Laboratories Div Pfizer Inc
- SpainBYTEQI 0,5 MG + 1 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGNeuraxpharm Spain S.L.
- CzechiaCHAMPIXPfizer Europe MA EEIG, Bruxelles
- United KingdomChampix 0.5mg tabletsMawdsley-Brooks & Company Ltd
- SwedenCHAMPIX 0,5 mg + 1 mg Filmdragerad tablettPfizer Europe MA EEIG
- FinlandChampixPfizer Europe MA EEIG
- BelgiumChampix 0.5 mgPfizer Europe MA
- NorwayApo-vareniclineApotex
Authorised across Europe · EMA
The same active substance is authorised in 18 EEA countries. Names it is sold under:
- Austria · Civarenix, Civarenix Starterpackung
- Belgium · Varenicline Ab, Varenicline Eg
- Czechia · Civarenix, Varenicline Glenmark
- Germany · Vareniclin Ascend, Vareniclin Axunio
- Denmark · Civarenix, Vareniclin Axunio
- Spain · Byteqi, Cuitvar
- Finland · Varenicline Glenmark, Varenicline Orion
- France · Varenicline, Varenicline Arrow
- United Kingdom (Northern Ireland) · Varenicline, Varenicline Accord
- Ireland · Varenicline Ascend, Varenicline Teva
- Iceland · Champix, Vareniclin Normon
- Italy · Civarenix, Vareniclina Aurobindo
- Liechtenstein · Champix
- Luxembourg · Vareniclin Ratiopharm, Vareniclin Starterpackung Ratiopharm
- Malta · Varenicline Glenmark
- Norway · Champix, Varenicline Bluefish
- Portugal · Cuitvar, Exchampra
- Sweden · Civarenix, Varenicline Bluefish
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ef9ff036-5ef3-413e-a96f-39d544255a6f GET /v1/drugs/ef9ff036-5ef3-413e-a96f-39d544255a6f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Filmomhulde tablet",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h132198_smpc.pdf",
"strength": null,
"atc_label": "Varenicline",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg132198",
"excipients": [
"CELLULOSE, MICROKRISTALLIJN (E 460(i))",
"CELLULOSE, MICROKRISTALLIJN (E 460(i))",
"CITROENZUUR 0-WATER (E 330)",
"CITROENZUUR 0-WATER (E 330)",
"HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
"HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
"INDIGOKARMIJN ALUMINIUMLAK (E 132)",
"MAGNESIUMSTEARAAT (E 470b)",
"MAGNESIUMSTEARAAT (E 470b)",
"MAÏSZETMEEL, GEPREGELATINEERD",
"MAÏSZETMEEL, GEPREGELATINEERD",
"PROPYLGALLAAT (E 310)",
"PROPYLGALLAAT (E 310)",
"TITAANDIOXIDE (E 171)",
"TITAANDIOXIDE (E 171)"
],
"substances": [
"VARENICLINECITRAAT",
"VARENICLINECITRAAT"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h132198.pdf",
"authorised_at": "2024/05/29",
"procedure_number": "NL/H/5947/003",
"dispensing_status": "Uitsluitend recept",
"registration_number": "132198",
"additional_monitoring": "N"
}See everything about varenicline.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.